Notice of Correction to Award Conditions for NOT-NS-23-001: "Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs"
Notice Number:
NOT-NS-23-020

Key Dates

Release Date:

August 2, 2022

Related Announcements

NOT-NS-23-001 - Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

This notice informs applicants of a change to the Applicationd and Submission Information section of NOT-NS-23-001 “Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs”. The Application and Submission Information section has been modified.

The following section of NOT-NS-23-001 “Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs” has been modified.

Currently Reads:

Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.

  • PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additions

  • Applications can only be submitted for existing NINDS awards.
  • Application Due Date(s) – August 19th, 2022, by 5:00 PM local time of applicant organization.
  • For funding consideration, applicants must include “NOT-NS-23-001” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
  • Requests may be for up to four years of support and cannot extend beyond the period of the parent award.
  • Application budgets must reflect the actual needs of the proposed project. Supplement budget requests are limited to 100% of the direct costs of the current year of the parent award (exclusive of Facilities and Administrative costs on sub-contracts) and may not exceed $250,000 in total costs per year. Applicants that want to propose higher budgets must receive permission from the project officer and IC Contact prior to submission.
  • Awards made under this NOSI are limited to one per parent award.
  • Applicants must be able to perform the research work without critically impacting other high-priority, on-going NINDS research programs.
  • The process for Streamlined Submissions using the eRA Commons cannot be used for this initiative.
  • The Research Strategy section of the application is limited to 6 pages.
  • The application Abstract section should describe the proposed supplement and the Research Strategy section should include a summary or abstract of the funded parent award or project. The Research Strategy should state the relevance to the parent award and AD/ADRD, and articulate the component(s) and any IC-specific priorities that the supplement is addressing.
  • Applicants are strongly encouraged to notify the program contact at NINDS that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request.

Modified to Read (changes shown in bold italics):

Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.

  • PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additions

  • Applications can only be submitted for existing NINDS awards.
  • Application Due Date(s) – August 19th, 2022, by 5:00 PM local time of applicant organization.
  • For funding consideration, applicants must include “NOT-NS-23-001” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
  • Requests may be for up to four years of support and cannot extend beyond the period of the parent award.
  • Application budgets must reflect the actual needs of the proposed project. Supplement budget requests are limited to 100% of the direct costs of the current year of the parent award (exclusive of Facilities and Administrative costs on sub-contracts) and may not exceed $250,000 in direct costs per year. Applicants that want to propose higher budgets must receive permission from the project officer and IC Contact prior to submission.
  • Awards made under this NOSI are limited to one per parent award.
  • Applicants must be able to perform the research work without critically impacting other high-priority, on-going NINDS research programs.
  • The process for Streamlined Submissions using the eRA Commons cannot be used for this initiative.
  • The Research Strategy section of the application is limited to 6 pages.
  • The application Abstract section should describe the proposed supplement and the Research Strategy section should include a summary or abstract of the funded parent award or project. The Research Strategy should state the relevance to the parent award and AD/ADRD, and articulate the component(s) and any IC-specific priorities that the supplement is addressing.
  • Applicants are strongly encouraged to notify the program contact at NINDS that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request.

All other aspects of the NOSI remain the same.

Inquiries

Please direct all inquiries to:

Carlos C. Faraco, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)

Division of Clinical Research
Telephone: 301-496-9135
Email: carlos.faraco@nih.gov